R&D Pipeline

S.No Vaccines Product Development Preclinical Testing Phase I Phase II Phase III Commercial License
1 Zika
2021
2 Chikungunya
2019
3 S. Paratyphi
2023
4 NTS Conjugates
2022
5 Human Papilloma Virus
2021
6 Acellular Pertussis
2021
7 Malaria PvRII
2022
8 Sabin IPV
2021
S. No. Therapeutics Product Development Preclinical Testing Phase I Phase II Phase III Commercial License
1 THR-100
2020
2 Lysostaphin Topical
2020
3 Lysostaphin IV
2020